OBJECTIVES: Malignant hyperthermia susceptibility is an important risk factor during
general anesthesia. Affected patients have an asymptomatic but potentially lethal …

Heatstroke not only directly induces cell injury, but also causes large amounts of
inflammatory mediators release and cells with extensive biological activities to induce a …

Postoperative malignant hyperthermia (MH) is a very rare phenomena. It is generally
observed within less than an hour after discontinuation of the anesthetic trigger. Present …

Malignant hyperthermia is a potentially life-threatening hypermetabolic disorder, often
induced by exposure to volatile anesthetics and succinylcholine. There are few reports of …

Hyperthermia not only directly induces cell injury of body tissues, but also causes the body
to release large amounts of inflammatory mediators and cells with extensive biological …

Objective Malignant hyperthermia (MH) is characterized by a state of hypermetabolism after
exposure to halogenated inhalational anesthetics or succinylcholine. The aims of this study …

Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane,
enflurane, isoflurane, sevoflurane, and desflurane) as well as succinylcholine and cause …

Malignant hyperthermia (MH) is a potentially lethal reaction in those that are genetically
predisposed, frequently triggered by inhaled anesthetics. MH is often difficult to diagnose …

Management of refractory status epilepticus is challenging for a neurointensivist consequent
to systemic complexities associated with various drugs and modalities involved in its …

Malignant hyperthermia (MH) is a potentially lethal hypermetabolic syndrome which can
develop after using volatile anesthetics (halothane, enflurane, isoflurane, sevoflurane, and …